These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 19389752
1. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Mult Scler; 2009 May; 15(5):644-6. PubMed ID: 19389752 [Abstract] [Full Text] [Related]
2. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Weiner HL. Ann Neurol; 2009 Mar; 65(3):239-48. PubMed ID: 19334069 [Abstract] [Full Text] [Related]
3. Adult stem cells in the treatment of autoimmune diseases. van Laar JM, Tyndall A. Rheumatology (Oxford); 2006 Oct; 45(10):1187-93. PubMed ID: 16777856 [Abstract] [Full Text] [Related]
4. Adult stem cell transplantation in autoimmune disease. Tyndall A, Gratwohl A. Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851 [Abstract] [Full Text] [Related]
5. Defining the response to multiple sclerosis treatment: the role of conventional magnetic resonance imaging. Rovaris M, Filippi M. Neurol Sci; 2005 Dec; 26 Suppl 4():S204-8. PubMed ID: 16388359 [Abstract] [Full Text] [Related]
6. At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only. Zwemmer JN, Bot JC, Jelles B, Barkhof F, Polman CH. Mult Scler; 2008 Apr; 14(3):428-30. PubMed ID: 18208890 [Abstract] [Full Text] [Related]
7. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation. Lu JQ, Storek J, Metz L, Yong VW, Stevens AM, Nash RA, Joseph JT. Arch Neurol; 2009 Jan; 66(1):116-20. PubMed ID: 19139309 [Abstract] [Full Text] [Related]
9. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A, Ciceri F, Schenone A, Parodi RC, Capello E, Comi G, Uccelli A. Mult Scler; 2005 Jun; 11(3):367-71. PubMed ID: 15957523 [Abstract] [Full Text] [Related]
10. Transplantation of mesenchymal stem cells enhances axonal outgrowth and cell survival in an organotypic spinal cord slice culture. Cho JS, Park HW, Park SK, Roh S, Kang SK, Paik KS, Chang MS. Neurosci Lett; 2009 Apr 17; 454(1):43-8. PubMed ID: 19429051 [Abstract] [Full Text] [Related]
11. Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia. Fang B, Song Y, Li N, Li J, Zhao RC. Acta Haematol; 2008 Apr 17; 119(3):162-5. PubMed ID: 18493117 [No Abstract] [Full Text] [Related]
12. Can the therapeutic advantages of allogenic umbilical cord blood-derived stem cells and autologous bone marrow-derived mesenchymal stem cells be combined and synergized? Heng BC, Phan TT, Liu H, Ouyang HW, Cao T. ASAIO J; 2006 Apr 17; 52(6):611-3. PubMed ID: 17117048 [No Abstract] [Full Text] [Related]
13. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. Kimiskidis V, Sakellari I, Tsimourtou V, Kapina V, Papagiannopoulos S, Kazis D, Vlaikidis N, Anagnostopoulos A, Fassas A. Mult Scler; 2008 Mar 17; 14(2):278-83. PubMed ID: 17942513 [Abstract] [Full Text] [Related]
14. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Christopeit M, Schendel M, Föll J, Müller LP, Keysser G, Behre G. Leukemia; 2008 May 17; 22(5):1062-4. PubMed ID: 17972956 [No Abstract] [Full Text] [Related]
15. In vivo tracking of dual-labeled mesenchymal stem cells homing into the injured common carotid artery. Cao AH, Shi HJ, Zhang Y, Teng GJ. Anat Rec (Hoboken); 2009 Oct 17; 292(10):1677-83. PubMed ID: 19685506 [Abstract] [Full Text] [Related]
16. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. Mathieu M, Bartunek J, El Oumeiri B, Touihri K, Hadad I, Thoma P, Metens T, da Costa AM, Mahmoudabady M, Egrise D, Blocklet D, Mazouz N, Naeije R, Heyndrickx G, McEntee K. J Thorac Cardiovasc Surg; 2009 Sep 17; 138(3):646-53. PubMed ID: 19698851 [Abstract] [Full Text] [Related]
17. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Shen J, Zhong XM, Duan XH, Cheng LN, Hong GB, Bi XB, Liu Y. Acad Radiol; 2009 Sep 17; 16(9):1142-54. PubMed ID: 19660710 [Abstract] [Full Text] [Related]
18. [Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis]. Lazebnik LB, Konopliannikov AG, Parfenov AI, Kniazev OV, Parfenov AI, Ruchkina IN, Khomeriki SG, Rogozina VA, Konopliannikova OA, Tsaregorodtseva TM. Eksp Klin Gastroenterol; 2009 Sep 17; (5):4-12. PubMed ID: 20205326 [Abstract] [Full Text] [Related]
19. MRI lesion loads and disability relationships in MS: more similar than different? Wolinsky JS. Neurology; 2009 Nov 10; 73(19):1524-5. PubMed ID: 19828867 [No Abstract] [Full Text] [Related]
20. Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis. Wundes A, Bowen JD, Kraft GH, Maravilla KR, McLaughlin B, von Geldern G, Georges G, Nash RA, Lu JQ. J Neurol Sci; 2017 Feb 15; 373():339-341. PubMed ID: 28131217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]